OBJECTIVE: To analyze the clinical efficacy of propoleum in Peyronie's disease. METHODS: A controlled, double-blind clinical trial based on a previous pilot study was conducted in 34 patients with Peyronie's disease treated with propoleum (Cuban Academy of Sciences patent no. 21875). The study was performed at the Freyre de Andrade Hospital in Habana. The clinical course and ultrasound features of the fibrous plaque were evaluated during a period of 6 months. RESULTS: A marked improvement was observed for penile curvature and pain in the treated group. Furthermore, plaque consistency and size was reduced five-fold after treatment and two-fold at ultrasound evaluation. No clinical or ultrasound changes were observed in the control group. CONCLUSIONS: Our results demonstrate the efficacy of propoleum in Peyronie's disease.
RCT Entities:
OBJECTIVE: To analyze the clinical efficacy of propoleum in Peyronie's disease. METHODS: A controlled, double-blind clinical trial based on a previous pilot study was conducted in 34 patients with Peyronie's disease treated with propoleum (Cuban Academy of Sciences patent no. 21875). The study was performed at the Freyre de Andrade Hospital in Habana. The clinical course and ultrasound features of the fibrous plaque were evaluated during a period of 6 months. RESULTS: A marked improvement was observed for penile curvature and pain in the treated group. Furthermore, plaque consistency and size was reduced five-fold after treatment and two-fold at ultrasound evaluation. No clinical or ultrasound changes were observed in the control group. CONCLUSIONS: Our results demonstrate the efficacy of propoleum in Peyronie's disease.
Authors: Young Hwii Ko; Ki Hak Moon; Sung Won Lee; Sae Woong Kim; Dae Yul Yang; Du Geon Moon; Woo Sik Chung; Kyung Jin Oh; Jae Seog Hyun; Ji Kan Ryu; Hyun Jun Park; Kwangsung Park Journal: Korean J Urol Date: 2014-01-15